Gabelli Funds’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $278K | Buy |
8,410
+1,910
| +29% | +$63.1K | ﹤0.01% | 1100 |
|
2025
Q1 | $261K | Buy |
6,500
+1,500
| +30% | +$60.3K | ﹤0.01% | 979 |
|
2024
Q4 | $235K | Sell |
5,000
-400
| -7% | -$18.8K | ﹤0.01% | 1000 |
|
2024
Q3 | $285K | Buy |
5,400
+400
| +8% | +$21.1K | ﹤0.01% | 965 |
|
2024
Q2 | $271K | Hold |
5,000
| – | – | ﹤0.01% | 958 |
|
2024
Q1 | $351K | Buy |
+5,000
| New | +$351K | ﹤0.01% | 930 |
|